SABCS 2023 | BRCA1 and hormone contraceptive use: impact on clinical decision-making

Kelly-Anne Phillips, MBBS (Hons), MD, FRACP, FAHMS, Peter MacCallum Cancer Center, Melbourne, Australia, shares her thoughts on what clinical decisions need to be made for patients carrying BRCA1 mutations, and their use of hormonal contraceptives in light of an increased breast cancer risk. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.